Markets
Pastel
BioScience intends to target its products and services primarily to the
pharmaceutical and biotechnology industries for incorporation into
their drug discovery and clinical development pipelines.
Pastel does however recognise that InVenio™ Technology and its InVenio™ biomarker discovery & validation platform have many applications in other areas including diagnostics, and in particular blood bank screening, in the discovery of unknown pathogenic organisms, e.g. SARS and avian flu viruses, and in civil protection programmes through its role as a monitor of biowarfare agents.
Components of the technologies being developed may also be applicable separately and Pastel is looking to leverage the value of these to shareholders through out-licensing and collaborations. These are addressed in the Technology section.
Pastel does however recognise that InVenio™ Technology and its InVenio™ biomarker discovery & validation platform have many applications in other areas including diagnostics, and in particular blood bank screening, in the discovery of unknown pathogenic organisms, e.g. SARS and avian flu viruses, and in civil protection programmes through its role as a monitor of biowarfare agents.
Components of the technologies being developed may also be applicable separately and Pastel is looking to leverage the value of these to shareholders through out-licensing and collaborations. These are addressed in the Technology section.
 |
||
|
||
|
||
|
||
|
||
|
||
|
||
|